Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: The Motley Fool
Novavax(NASDAQ:NVAX 00Investors are hopeful that Novavax will make a fortune off its potential vaccine for COVID-9. However, as several other biotech companies are looking to develop vaccines or treatments for COVID-9, betting that Novavax will win that race is a bit speculative at this point. Still, there is another potential catalyst for Novavax on the way, and this arguably makes the company worth a second look.Novavax's NanoFlu vaccine could be a significant growth driverNovavax focuses on the development of vaccines for infectious diseases. The company does not currently have any products on the market, but one of its lead pipeline candidates is a potential flu vaccine called NanoFlu, which is being developed specifically for adults over the age of 6.Of course, there are other vaccines for the flu on the market, but Novavax argues that its NanoFlu has a chance to be more effective than some of the current market leaders. For instance, in a clinical trial pitting NanoFlu againstSa
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXAccesswire
- How Technology Makes The CFO's Job More About Driving Value [Forbes]Forbes
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAXPR Newswire
- How Health, Innovation And A Bit Of Friction Help Pharmavite Succeed [Forbes]Forbes
NVAX
Earnings
- 11/12/24 - Beat
NVAX
Sec Filings
- 11/20/24 - Form 8-K
- 11/13/24 - Form 4
- 11/13/24 - Form 3
- NVAX's page on the SEC website